MX380385B - Agente para el tratamiento de infeccion respiratoria. - Google Patents

Agente para el tratamiento de infeccion respiratoria.

Info

Publication number
MX380385B
MX380385B MX2017011040A MX2017011040A MX380385B MX 380385 B MX380385 B MX 380385B MX 2017011040 A MX2017011040 A MX 2017011040A MX 2017011040 A MX2017011040 A MX 2017011040A MX 380385 B MX380385 B MX 380385B
Authority
MX
Mexico
Prior art keywords
respiratory infection
agent
treatment
treating agent
infection treating
Prior art date
Application number
MX2017011040A
Other languages
English (en)
Other versions
MX2017011040A (es
Inventor
Hirotaka Ando
Hisao Yoshida
Kota Kume
Yuta Tanaka
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of MX2017011040A publication Critical patent/MX2017011040A/es
Publication of MX380385B publication Critical patent/MX380385B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

[Problema] La presente invención se refiere a un agente para el tratamiento de infección respiratoria más seguro y más efectivo. [Solución] Un agente para el tratamiento de infección respiratoria contiene, como un ingrediente activo, ácido 7-[(3S,4S)-3-{(ciclopropilamino)metil}-4-fluoropirrolidin-1-il]-6-fluoro-1-(2-fluoroetil)-8-metoxi-4-oxo-1,4-dihidroquinolin-3-carboxílico o una sal farmacéuticamente aceptable del mismo.
MX2017011040A 2015-03-13 2016-03-11 Agente para el tratamiento de infeccion respiratoria. MX380385B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015051206 2015-03-13
JP2015136944 2015-07-08
PCT/JP2016/057797 WO2016148066A1 (ja) 2015-03-13 2016-03-11 呼吸器感染症治療剤

Publications (2)

Publication Number Publication Date
MX2017011040A MX2017011040A (es) 2017-11-10
MX380385B true MX380385B (es) 2025-03-12

Family

ID=56920174

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011040A MX380385B (es) 2015-03-13 2016-03-11 Agente para el tratamiento de infeccion respiratoria.

Country Status (15)

Country Link
US (3) US20180042918A1 (es)
EP (1) EP3269369A4 (es)
JP (1) JP6077725B1 (es)
KR (1) KR102532681B1 (es)
CN (2) CN113975277B (es)
AU (1) AU2016234411C1 (es)
BR (1) BR112017019205A2 (es)
CA (1) CA2978261A1 (es)
EA (1) EA201791995A1 (es)
IL (1) IL253878A0 (es)
MX (1) MX380385B (es)
MY (1) MY191848A (es)
PH (1) PH12017501505B1 (es)
SG (2) SG10201908007UA (es)
WO (1) WO2016148066A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019025960A2 (pt) * 2017-06-16 2020-11-03 Kyorin Pharmaceutical Co., Ltd. agente terapêutico para pneumonia aspirativa, supuração pulmonar ou abcesso pulmonar
WO2018230686A1 (ja) * 2017-06-16 2018-12-20 杏林製薬株式会社 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173484A (en) * 1988-02-05 1992-12-22 Bayer Aktiengesellschaft Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
TW425394B (en) * 1996-04-24 2001-03-11 Daiichi Seiyaku Co Antimicrobial quinolone derivatives having 3-(N-cycloalkyl) aminomethylpyrrolidine group
ATE443064T1 (de) 2002-03-18 2009-10-15 Kyorin Seiyaku Kk 10-(3-cyclo propyl amino methyl-1-pyrrolidinyl) pyridobenzoxazin carbonsäure derivat mit wirkung gegen resistente bakterien
SI1666477T1 (sl) 2003-09-10 2013-10-30 Kyorin Pharmaceutical Co., Ltd. Derivati 7-(4-substituiran 3-ciklopropilaminometil-1-pirolidinil) kinolonkarboksilne kisline
DE102007027618A1 (de) 2007-06-12 2008-12-18 Rehau Ag + Co Verfahren zur Vorbehandlung von zu lackierenden polymeren Oberflächen
WO2013006854A2 (en) * 2011-07-07 2013-01-10 Indiana University Research And Technology Corporation Compositions and methods for treating enterobacteriaceae
SA112330992B1 (ar) * 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي
JP6062422B2 (ja) * 2012-03-29 2017-01-18 杏林製薬株式会社 カプセル製剤
WO2014174848A1 (ja) * 2013-04-25 2014-10-30 杏林製薬株式会社 錠剤

Also Published As

Publication number Publication date
WO2016148066A1 (ja) 2016-09-22
EP3269369A1 (en) 2018-01-17
US20210052572A1 (en) 2021-02-25
SG10201908007UA (en) 2019-10-30
CN107427507B (zh) 2021-12-17
AU2016234411C1 (en) 2020-04-30
US10918634B2 (en) 2021-02-16
PH12017501505A1 (en) 2018-02-05
MX2017011040A (es) 2017-11-10
CA2978261A1 (en) 2016-09-22
IL253878A0 (en) 2017-10-31
JP6077725B1 (ja) 2017-02-08
US20190076421A1 (en) 2019-03-14
CN113975277A (zh) 2022-01-28
AU2016234411A1 (en) 2017-09-07
SG11201706951XA (en) 2017-09-28
EP3269369A4 (en) 2018-11-07
KR20170123695A (ko) 2017-11-08
MY191848A (en) 2022-07-18
JPWO2016148066A1 (ja) 2017-04-27
KR102532681B1 (ko) 2023-05-15
PH12017501505B1 (en) 2018-02-05
US20180042918A1 (en) 2018-02-15
AU2016234411B2 (en) 2020-01-30
BR112017019205A2 (pt) 2018-04-24
CN107427507A (zh) 2017-12-01
EA201791995A1 (ru) 2017-12-29
CN113975277B (zh) 2024-10-18

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
PH12019501685A1 (en) Quinazone compound
BR112017003054A2 (pt) compostos de aminopirimidinila como inibidores de jak
NZ733174A (en) Quinazoline derivatives used to treat hiv
PH12015501891A1 (en) Novel bacteriophage and antibacterial composition comprising the same
PH12015501890A1 (en) Novel bacteriophage and antibacterial composition comprising the same
PH12016502003A1 (en) Novel bacteriophage and composition containing same
MX394588B (es) Composición farmacéutica.
PH12016501999A1 (en) Novel bacteriophage and composition containing same
PH12016502001B1 (en) Novel bacteriophage and composition comprising same
EA201890906A1 (ru) ПРОИЗВОДНЫЕ ХИНОКСАЛИНА И ПИРИДОПИРАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ
EA201890412A1 (ru) АНТИБАКТЕРИАЛЬНЫЕ АГЕНТЫ, СОДЕРЖАЩИЕ ПИРАЗИНО[2,3-b][1,4]ОКСАЗИН-3-ОН ИЛИ РОДСТВЕННУЮ КОЛЬЦЕВУЮ СИСТЕМУ
MX389589B (es) Dexmedetomidina o medetomidina para uso en el tratamiento de la ansiedad por separacion en perros.
EA202191683A1 (ru) Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии
ZA201807495B (en) Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof
EP3404020A4 (en) PYRIDINOL DERIVATIVE OR PHARMACEUTICALLY SAFE SALT THEREOF AND PHARMACEUTICAL COMPOSITION THEREFORE AS AN ACTIVE SUBSTANCE
MX380385B (es) Agente para el tratamiento de infeccion respiratoria.
EA201890419A1 (ru) ОТСЕЛЕКТИРОВАННЫЙ АМИД γ-ГИДРОКСИМАСЛЯНОЙ КИСЛОТЫ И ЕГО ПРИМЕНЕНИЯ ПРИ ЛЕЧЕНИИ ЗЛОУПОТРЕБЛЕНИЯ АЛКОГОЛЕМ
SI3882244T1 (sl) Spojina, farmacevtsko sprejemljiva sol ali optični izomer le-te, postopek za njeno pripravo in farmacevtski sestavek za preprečevanje ali zdravljenje virusnih bolezni, ki jo vsebuje kot učinkovino
EA201992234A1 (ru) Средство для профилактики миопии, лечения миопии и/или предотвращения прогрессирования миопии, включающее тиотропий в качестве активного ингредиента
EA201890789A1 (ru) Содержащая цинеол композиция для лечения заболеваний носа
MX387252B (es) EL USO DE DERIVADOS DE QUINOLINONAS QUE TIENE UNA ACTIVIDAD DE INHIBICIÓN DE LA FORMACIÓN DEL COMPLEJO DE C-Myc/Max/ADN EN EL TRATAMIENTO DE CANCER.
PH12019502835A1 (en) Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess
MA41158A (fr) Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenat de l'azote bicyclique en tant que principe actif
MY200429A (en) Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess